Mostrar el registro sencillo del ítem

Dermatosis prevalentes asociadas a obesidad en pacientes de consulta Externa de la Fundación Oftalmológica de Santander – Foscal

dc.contributor.advisorMosquera Sánchez, Hernandospa
dc.contributor.advisorSerrano Gómez, Sergio Eduardospa
dc.contributor.authorFajardo Reyes, Camilaspa
dc.coverage.spatialFloridablanca (Santander, Colombia)spa
dc.date.accessioned2020-08-06T23:26:01Z
dc.date.available2020-08-06T23:26:01Z
dc.date.issued2020
dc.identifier.urihttp://hdl.handle.net/20.500.12749/7178
dc.description.abstractIntroducción: La obesidad y el sobrepeso se definen como un aumento anormal o exagerado de grasa que puede tener distintas consecuencias en la salud. La organización mundial de la salud define la obesidad como un índice de masa corporal (IMC) superior a 30 y el sobrepeso un IMC superior a 25. Desde 1975 la prevalencia de la obesidad se ha triplicado y cifras recientes de 2016 indican que hasta el 39% de la población mundial mayor de 18 años tiene sobrepeso y el 13% tiene obesidad. En dermatología existe una importante asociación entre el sobrepeso, la obesidad y diferentes afecciones cutáneas de tipo infecciosas, inflamatorias, secundarias a factores mecánicos, metabólicos y asociadas a la resistencia a la insulina que pueden llegar a afectar seriamente la salud de la piel y la calidad de vida de los pacientes. Objetivo: Establecer la frecuencia y asociación de la obesidad y las patologías dermatológicas en la consulta externa de FOSCAL entre Noviembre 2019 – Marzo 2020. Materiales y métodos: Estudio transversal analítico con 826 pacientes con peso normal, sobrepeso y obesidad, donde por medio de una encuesta verbal, se tomaron datos sociodemógraficos y mediante un exámen físico dermatológico se identificarón y clasificaron las lesiones cutáneas asociadas a obesidad. Resultados: En total se inlcuyeron 826 pacientes entre edades de 18 a 65 años, el 72% (598) fueron mujeres y el 27% (228) fueron hombres. El 57% del total de los encuestados tienen un peso normal, el 32.1 % presenta sobrepeso, el 7.9% obesidad grado I, 1.2% obesidad grado II y 0.97% obesidad grado III. Los hombres presentan mayor prevalencia de sobrepeso (40.30% hombres Vs 29% mujeres) así como de obesidad (10.90% hombres Vs 9.7% mujeres). Las dermatosis que se asociaron de una menera estadísticamente significativa a la obesidad fueron acantosis nigricans, fibromas laxos, estrías por distensión, celulitis (lipodistrofia ginecoide), hiperqueratosis plantar, insuficiencia venosa crónica, forunculosis y psoriasis. Conclusiones: La obesidad y el sobrepeso se asocian de manera importante a múltiples lesiones cutáneas de diferente etiología. La prevalencia reportada en este estudio es similar a la global, sin embargo los hombres mostraron mayores tasas de sobrepeso y obesidad comparado con las mujeres. Las dermatosis reportadas en este estudio que se asociarón de una manera estadísticamente significativa a obesidad deben ser reconocidas como marcadores de estre trastorno. Entender la relación entre la piel y las alteraciones del peso es importante para el diagnóstico temprano y el tratamiento de sus complicaciones.spa
dc.description.tableofcontents1 RESUMEN DEL PROYECTO: ....................................................................................... 8 2 DESCRIPCIÓN DEL PROYECTO ................................................................................... 9 2.1 Planteamiento del problema y justificación ...................................................... 9 2.2 Marco teórico ................................................................................................. 10 2.3 Estado del arte ................................................................................................ 17 2.4 Objetivos del estudio ...................................................................................... 23 2.4.1 Objetivo general ......................................................................................................................... 23 2.4.2 Objetivos específicos .................................................................................................................. 23 2.5 Metodología ................................................................................................... 23 2.5.1 Criterios de inclusión: ................................................................................................................. 23 2.5.2 Criterios de exclusión: ................................................................................................................. 23 2.5.3 Cálculo del tamaño de la muestra: ............................................................................................. 23 2.5.4 Muestreo .................................................................................................................................... 24 2.5.5 Recolección de la información .................................................................................................... 24 2.5.6 Definición de variables ................................................................................................................ 25 2.6 Plan de análisis de datos ................................................................................. 30 2.7 Consideraciones éticas .................................................................................... 30 3 RESULTADOS: ........................................................................................................ 31 3.1 CARACTERÍSTICAS DE LA POBLACIÓN: ............................................................. 31 3.2 VARIABLES SOCIODEMOGRÁFICAS .................................................................. 32 3.3 VARIABLES DERMATOLÓGICAS ....................................................................... 35 4 DISCUSIÓN: ............................................................................................................ 44 5 CONCLUSIONES ...................................................................................................... 50 6 BIBLIOGRAFÍA ........................................................................................................ 51 7 ANEXOS ................................................................................................................. 56spa
dc.format.mimetypeapplication/pdfspa
dc.language.isoesspa
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/2.5/co/*
dc.subject.meshEnfermedades cutáneasspa
dc.subject.meshPruebas cutáneasspa
dc.subject.meshMetabolismospa
dc.subject.meshEnfermedades de la pielspa
dc.titleDermatosis prevalentes asociadas a obesidad en pacientes de consulta Externa de la Fundación Oftalmológica de Santander – Foscalspa
dc.typeThesiseng
dc.title.translatedPrevalent dermatoses associated with obesity in outpatients of the Fundación Oftalmológica de Santander - Foscaleng
dc.degree.nameEspecialista en Dermatologíaspa
dc.publisher.grantorUniversidad Autónoma de Bucaramanga UNABspa
dc.rights.localAbierto (Texto Completo)spa
dc.publisher.facultyFacultad Ciencias de la Saludspa
dc.publisher.programEspecialización en Dermatologíaspa
dc.description.degreelevelEspecializaciónspa
dc.type.driverinfo:eu-repo/semantics/masterThesis
dc.type.localTesisspa
dc.type.coarhttp://purl.org/coar/resource_type/c_bdcc
dc.subject.keywordsDermatologyeng
dc.subject.keywordsMedical scienceseng
dc.subject.keywordsHealth scienceseng
dc.subject.keywordsObesityeng
dc.subject.keywordsOverweighteng
dc.subject.keywordsDermatoseseng
dc.subject.keywordsAcanthosis nigricanseng
dc.subject.keywordsCelluliteeng
dc.subject.keywordsPlantar hyperkeratosiseng
dc.subject.keywordsSkin diseaseseng
dc.subject.keywordsSkin testseng
dc.subject.keywordsMetabolismeng
dc.subject.keywordsSkin diseaseseng
dc.identifier.instnameinstname:Universidad Autónoma de Bucaramanga - UNABspa
dc.identifier.instnameinstname:Universidad Autónoma de Bucaramanga - UNABspa
dc.identifier.reponamereponame:Repositorio Institucional UNABspa
dc.identifier.reponamereponame:Repositorio Institucional UNABspa
dc.type.hasversioninfo:eu-repo/semantics/acceptedVersion
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.rights.accessrightshttp://purl.org/coar/access_right/c_abf2spa
dc.relation.references1. García Hidalgo L. Dermatological Complications of Obesity. Am J Clin Dermatol. 2006;3(7):497–506.spa
dc.relation.references2. Geometry R, Analysis G. Estadísticas sanitarias mundiales 2012.spa
dc.relation.references3. Rikli R, Jone J. Obesity and overweight. Hum Kinet. 2013;200.spa
dc.relation.references4. ICBF. Resumen Ejecutivo Encuesta Nacional de la Situación Nutricional en Colombia, ENSIN 2015. Ensin [Internet]. 2015;24. Available from: https://www.icbf.gov.co/bienestar/nutricion/encuesta-nacional-situacionnutricional# ensin3spa
dc.relation.references5. Heit JA. Venous Thromboembolism Epidemiology: Implications for Prevention and Management. Semin Thromb Hemost. 2002;28(s2):003–14.spa
dc.relation.references6. García Solís O, Medina Castillo DE, De La Cruz López J, Huerta Alvarado S, Díaz Guadarrama I, Velázquez Canchola F, et al. Obesidad y dermatosis: Estudio prospectivo y descriptivo en la clínica de consulta externa Alfredo del Mazo Vélez del ISSEMyM, Toluca. Dermatologia Rev Mex. 2010;54(1):3–9.spa
dc.relation.references7. Yosipovitch G, DeVore A, Dawn A. Obesity and the skin: Skin physiology and skin manifestations of obesity. J Am Acad Dermatol. 2007;56(6):901–16.spa
dc.relation.references8. Enzi G, Busetto L, Inelmen EM, Coin A, Sergi G. Historical perspective: Visceral obesity and related comorbidity in Joannes Baptista Morgagni’s “De Sedibus et Causis Morborum per Anatomen Indagata.” Int J Obes. 2003;27(4):534–5.spa
dc.relation.references9. Pineda CA. Metabolic syndrome: definition, history, criterion. Colomb Med [Internet]. 2008;39(1):96–106. Available from: http://colombiamedica.univalle.edu.co/index.php/comedica/article/view/556/949spa
dc.relation.references10. Scheinfeld NS. Obesity and dermatology. Clin Dermatol. 2004;22(4 SPEC. ISS.):303–9.spa
dc.relation.references11. Alberta S. Kong, Robert L. Williams et al. Acanthosis nigricans: high prevalence and association with diabetes in a practice-based research network consortium - a PRImary care Multi-Ethnic Network (PRIME Net) study. J Am Board Fam Med. 2017;32(7):736–40.spa
dc.relation.references12. Al. CAS et. Acanthosis nigricans. J Basic Clin Physiol Pharmacol. 1998;9:407–18.spa
dc.relation.references13. Uzuncakmak TK, Akdeniz N, Karadag AS. Cutaneous manifestations of obesity and themetabolic syndrome. Clin Dermatol. 2018;36(1):81–8.spa
dc.relation.references14. Tamega ADA, Aranha AMP, Guiotoku MM, Miot LDB, Miot HA. Associação entre acrocórdons e resistência à insulina. An Bras Dermatol. 2010;85(1):25–31.spa
dc.relation.references15. García-Hidalgo L, Orozco-Topete R, Gonzalez-Barranco J, Villa AR, Dalman JJ, Ortiz- Pedroza G. Dermatoses in 156 obese adults. Obes Res. 1999;7(3):299–302.spa
dc.relation.references16. Martínez-Hernández JA, Martínez-Urbistondo D, Carapeto Márquez de Prado FJ. Manifestaciones cutáneas en la obesidad. Rev Española Nutr Humana y Dietética [Internet]. 2011;15(2):56–61. Available from: http://dx.doi.org/10.1016/S2173- 1292(11)70011-4spa
dc.relation.references17. Tobin AM, Ahern T, Rogers S, Collins P, O’Shea D, Kirby B. The dermatological consequences of obesity. Int J Dermatol. 2013;52(8):927–32.spa
dc.relation.references18. Wolf AM, Kuhlmann HW. Reconstructive procedures after massive weight loss. Obes Surg. 2007;17(3):355–60.spa
dc.relation.references19. De Kerviler S, Hüsler R, Banic A, Constantinescu MA. Body contouring surgery following bariatric surgery and dietetically induced massive weight reduction: A risk analysis. Obes Surg. 2009;19(5):553–9.spa
dc.relation.references20. Holick MF, Chen TC, Lu Z, Wortsman J, Matsuoka LY. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr. 2018;72(3):690–3.spa
dc.relation.references21. Kechichian E, Ezzedine K. Vitamin D and the Skin: An Update for Dermatologists. Am J Clin Dermatol. 2018;19(2):223–35.spa
dc.relation.references22. Guida B, Nino M, Perrino NR, Laccetti R, Trio R, Labella S, et al. The impact of obesity on skin disease and epidermal permeability barrier status. J Eur Acad Dermatology Venereol. 2010;24(2):191–5.spa
dc.relation.references23. Kutlubay Z, Engin B, Bairamov O, Tüzün Y. Acanthosis nigricans: A fold (intertriginous) dermatosis. Clin Dermatol [Internet]. 2015;33(4):466–70. Available from: http://dx.doi.org/10.1016/j.clindermatol.2015.04.010spa
dc.relation.references24. Eberting CLD, Javor E, Gorden P, Turner ML, Cowen EW. Insulin resistance, acanthosis nigricans, and hypertriglyceridemia. J Am Acad Dermatol. 2005;52(2):341–4.spa
dc.relation.references25. Sinha S, Schwartz RA. Juvenile acanthosis nigricans. J Am Acad Dermatol. 2007;57(3):502–8.spa
dc.relation.references26. Wang JF, Orlow SJ. Keratosis Pilaris and its Subtypes: Associations, New Molecular and Pharmacologic Etiologies, and Therapeutic Options. Am J Clin Dermatol [Internet]. 2018;19(5):733–57. Available from: https://doi.org/10.1007/s40257-018-0368-3spa
dc.relation.references27. Yosipovitch G, Mevorah B, Mashiach J, Chan YH DM. High body mass index, dry scaly leg skin and atopic conditions are highly associated with keratosis pilaris. Dermatology. 2000;201(1):34–6.spa
dc.relation.references28. Shaheen MA, Abdel Fattah NSA, Sayed YAA, Saad AA. Assessment of serum leptin, insulin resistance and metabolic syndrome in patients with skin tags. J Eur Acad Dermatology Venereol. 2012;26(12):1552–7.spa
dc.relation.references29. Carolina Guerra-Segovia JO-C. Dermatosis en la obesidad. Rev Med Inst Mex Seguro Soc. 2015;53(2):180–9.spa
dc.relation.references30. EFTYCHIA PLATSIDAKI, MD; VARVARA VASALOU, MD; MARIA GERODIMOU, MD; VASILIKI MARKANTONI. The Association of Various Metabolic Parameters with Multiple Skin Tags. J Clin Aesthet Dermatol. 2018;11(10):40–3.spa
dc.relation.referencesBanik R. · Lubach D. Skin Tags: Localization and Frequencies According to Sex and Age. Dermatologica. 1987;174(c):180–3.spa
dc.relation.references32. Wali V V., Wali V V. Assessment of various biochemical parameters and BMI in patients with skin tags. J Clin Diagnostic Res. 2016;10(1):BC09-BC11.spa
dc.relation.references33. Plascencia Gómez A, Vega Memije ME, Torres Tamayo M, Rodríguez Carreón AA. Dermatosis en pacientes con sobrepeso y obesidad y su relación con la insulina. Actas Dermosifiliogr [Internet]. 2013;105(2):178–85. Available from: http://dx.doi.org/10.1016/j.ad.2013.09.008spa
dc.relation.references35. S. Al-Himdani, S. Ud-Din SG and AB, 1. Striae distensae: A comprehensive review and evidence based evaluation of prophylaxis and treatment. Br J Dermatol. 2014;170:527–47.spa
dc.relation.references36. Cho S, Park ES, Lee DH, Li K, Chung JH. Clinical features and risk factors for striae distensae in Korean adolescents. J Eur Acad Dermatology Venereol. 2006;20(9):1108– 13.spa
dc.relation.references37. Osman H, Rubeiz N, Tamim H, Nassar AH. Risk factors for the development of striae gravidarum. Am J Obstet Gynecol [Internet]. 2007;196(1):62.e1-62.e5. Available from: http://dx.doi.org/10.1016/j.ajog.2006.08.044spa
dc.relation.references38. Friedmann DP, Vick GL, Mishra V. Cellulite: A review with a focus on subcision. Clin Cosmet Investig Dermatol. 2017;10:17–23.spa
dc.relation.references39. Beatris A, Rossi R, Luiz Vergnanini A. Cellulite: a review Concept and nomenclature. Eur Acad Dermatology Venereol. 2000;14:251–62.spa
dc.relation.references40. Ferriman D GJ. Clinical assessment of body hair in women. J Clin Endocrinol Meta. 1961;21(January):1440–7.spa
dc.relation.references41. García Blanco L, Azcona San Julián C. Hiperandrogenismo: Pubarquia precoz y syndrome de ovario poliquístico. etiología y posibilidades terapéuticas. Pediatr Aten Primaria. 2012;14(53):61–7.spa
dc.relation.references42. Vergara JI, Ríos X, Wandurraga EA, Rey JJ. Evaluación clínica del pelo corporal en una población de mujeres colombianas: determinación del punto de corte para el diagnóstico de hirsutismo. Biomédica. 2013;33(3):370–4.spa
dc.relation.references43. Alikhan A, Sayed C, Alavi A, Alhusayen R, Brassard A, Burkhart C, et al. North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part I: Diagnosis, evaluation, and the use of complementary and procedural management. J Am Acad Dermatol [Internet]. 2019;81(1):76–90. Available from: https://doi.org/10.1016/j.jaad.2019.02.067spa
dc.relation.references44. Zouboulis CC, Desai N, Emtestam L, Hunger RE, Ioannides D, Juhász I, et al. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa. J Eur Acad Dermatology Venereol. 2015;29(4):619–44.spa
dc.relation.references45. Saunte DML, Jemec GBE. Hidradenitis suppurativa: Advances in diagnosis and treatment. JAMA - J Am Med Assoc. 2017;318(20):2019–32.spa
dc.relation.references46. Kromann CB, Ibler KS, Kristiansen VB, Jemec GBE. The influence of body weight on the prevalence and severity of hidradenitis suppurativa. Acta Derm Venereol. 2014;94(5):553–7.spa
dc.relation.references47. de Oliveira M de FSP, Rocha B de O, Duarte GV. Psoriasis: Classical and emerging comorbidities. An Bras Dermatol. 2015;90(1):09–20.spa
dc.relation.references48. Jensen P, Skov L. Psoriasis and Obesity. Dermatology. 2017;232(6):633–9.spa
dc.relation.references49. Henseler T, Christophers E. Disease concomitance in psoriasis. J Am Acad Dermatol. 1995;32(6):982–6.spa
dc.relation.references50. Andersen YMF, Egeberg A. Seborrhoeic dermatitis – understood or understudied? Br J Dermatol [Internet]. 2019;bjd.18307. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1111/bjd.18307spa
dc.relation.references51. Hud JA, Cohen JB, Wagner JM. Prevalence and Significance of Acanthosis Nigricans in an Adult Obese Population Acanthosi s. Arch dermatol. 1992;128:941–4.spa
dc.relation.references52. Beebe-Dimmer JL, Pfeifer JR, Engle JS, Schottenfeld D. The epidemiology of chronic venous insufficiency and varicose veins. Ann Epidemiol. 2005;15(3):175–84.spa
dc.relation.references53. Guzmán-Sánchez DA. Alopecia androgenética. Dermatologia Rev Mex. 2015;59(5):387–94.spa
dc.relation.references54. Hirt, P. A., Castillo, D. E., Yosipovitch, G., & Keri, J. E. (2019). Skin changes in the obese patient. Journal of the American Academy of Dermatology, 81(5), 1037-1057.spa
dc.relation.references55. Al-Mutairi, N. (2011). Associated Cutaneous Diseases in Obese Adult Patients: A Prospective Study from a Skin Referral Care Center. Medical Principles and Practice, 20(3), 248-252.spa
dc.relation.references56. Shin H, Ryu HH, Yoon J, et al. Association of premature hair graying with family history, smoking, and obesity: a cross- sectional study. J Am Acad Dermatol. 2015;72(2):321- 327.spa
dc.relation.references57. Woollons A, Darley CR, Lee PJ, Brenton DP, Sonksen PH, Black MM. Cutis verticis gyrata of the scalp in a patient with autosomal dominant insulin resistance syndrome. Clin Exp Dermatol. 2000;25(2):125-128.spa
dc.relation.references58. Gerstenblith M, Rajaraman P, Khaykin E, et al. Basal cell carcinoma and anthropometric factors in the U.S. radiologic technologists cohort study. Int J Cancer. 2012;131(2):E149- E155.spa
dc.relation.references59. Thune I, Olsen A, Albrektsen G, Tretli S. Cutaneous malignant melanoma: association with height, weight and body-surface area. A prospective study in Norway. Int J Cancer. 1993;55(4): 555-561.spa
dc.relation.references60. Silverberg J, Kleiman E, Lev-Tov H, et al. Association between obesity and atopic dermatitis in childhood: a case-control study. J Allergy Clin Immunol. 2011;127(5): 1180-1186.spa
dc.relation.references61. Peña J y col. Lipodistrofia ginecoide. Rev Cent Dermatol Pascua. Vol 14, Num. 3 2005.spa
dc.contributor.cvlachttps://scienti.minciencias.gov.co/cvlac/visualizador/generarCurriculoCv.do?cod_rh=0000128352*
dc.contributor.cvlachttps://scienti.minciencias.gov.co/cvlac/visualizador/generarCurriculoCv.do?cod_rh=0000533254*
dc.contributor.cvlachttps://scienti.minciencias.gov.co/cvlac/visualizador/generarCurriculoCv.do?cod_rh=0001521095*
dc.contributor.orcidhttps://orcid.org/0000-0001-6418-7116*
dc.contributor.orcidhttps://orcid.org/0000-0001-6418-7116*
dc.contributor.scopushttps://www.scopus.com/authid/detail.uri?authorId=57193495766*
dc.contributor.scopushttps://www.scopus.com/authid/detail.uri?authorId=57197758865*
dc.subject.lembDermatologíaspa
dc.subject.lembCiencias médicasspa
dc.subject.lembMedicinaspa
dc.identifier.repourlrepourl:https://repository.unab.edu.cospa
dc.identifier.repourlrepourl:https://repository.unab.edu.co
dc.description.abstractenglishBackground: Obesity and overweight have been defined as an abnormal or exaggerated increase in fat which can have different consequences in human health. The world health organization (WHO) defines obesity as a body mass index over 30 and overweight as a body mass index over 25. Since 1975 obesity prevalence has tripled and recent studies from 2016 show that 39% of the global population over 18 years old is overweight and 13% suffer from obesity. In dermatology there is an important association between overweight, obesity and cutaneous diseases from different etiologies; such as inflammatory conditions, infectious diseases, changes associated with mechanical or metabolic factors, and cutaneous lesions related to insulin resistance. These dermatoses can have a serious impact on skin health and patient’s quality of life. Objective: Establish the frequency and association between obesity and cutaneous pathologies in external consultation patients from: Fundación Oftalmológica de Santander - FOSCAL between November 2019 and March 2020. Methods: Analytical cross-sectional study with 826 patients of normal weight, overweight and obesity were included. During an oral survey, sociodemographic information was taken. Then a dermatological physical examination was performed, and cutaneous lesions associated with obesity were identified and classified. Results: 826 patients of ages 18 to 65 years old were included. Of these, 72% (598) were female and 27% (228) were male. 57% of patients were normal weight, 32,1% being overweight, 7.9% showed obesity grade and 1.2% obesity grade II only 0.97% were grade III. Male patients presented a higher prevalence of overweight than female patients (40.3 Vs 29% respectively). Obesity was also more prevalent in male patients than female (10.90% Vs 9.7% respectively). The dermatoses statistically related to obesity were acanthosis nigricans, acrochordons, striae distensae, cellulite, plantar hyperkeratosis, chronic venous insufficiency, furuncles and psoriasis. Conclusion: Obesity and overweight are importantly associated with multiple cutaneous diseases. The prevalence of weight disturbances reported in this study is similar to that of a global scale, however male patients present higher obesity and overweight rates than female. Dermatoses statistically related to the obese patient in this study should be recognize as markers weight disturbance. Understand the relation between skin and weight abnormalities is important for the early diagnosis and treatment of its complications.eng
dc.subject.proposalCiencias de la saludspa
dc.subject.proposalObesidadspa
dc.subject.proposalSobrepesospa
dc.subject.proposalDermatosisspa
dc.subject.proposalAcantosis nigrincansspa
dc.subject.proposalLipodistrofia ginecoidespa
dc.subject.proposalHiperqueratosis plantarspa
dc.subject.proposalFundación Oftalmológica de Santander (FOSCAL)spa
dc.type.redcolhttp://purl.org/redcol/resource_type/TMspa
dc.rights.creativecommonsAtribución-NoComercial-SinDerivadas 2.5 Colombia*
dc.coverage.campusUNAB Campus Bucaramangaspa
dc.description.learningmodalityModalidad Presencialspa


Ficheros en el ítem

Thumbnail
Nombre:
2020_Tesis_Camila_Fajardo_Reyes.pdf
Tamaño:
1.604Mb
Formato:
PDF
Descripción:
Tesis
Ver/
Thumbnail
Nombre:
2020_Licencia_Camila_Fajardo_R ...
Tamaño:
703.7Kb
Formato:
PDF
Descripción:
Licencia
Ver/

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución-NoComercial-SinDerivadas 2.5 Colombia
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución-NoComercial-SinDerivadas 2.5 Colombia